brexucabtagene autoleucel
gilead sciences
['lymsm', 'tecartus', 'brexu-cel', 'car t', 'cart,(-cartitude)']
the car t-cell therapy brexu-cel (brexu-cel, tecartus; kite), has shown favorable efficacy and safety for the treatment of r/r mcl in clinical practice, according to results from a real-world experience study. #asco22 #lymsm 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.